You are not imagining it, and you are not alone. Weight and body composition change is one of the most well-documented, commonly experienced side effects of psychiatric medication<\/strong> \u2014 by some clinical estimates, affecting more than half of people on long-term antidepressant treatment. It is real, it has a specific physiological explanation, and \u2014 this needs saying plainly, before anything else \u2014 it is not a reason to feel ashamed, and never, on its own, a reason to stop medication that is helping you. This article explains what’s actually happening in your body, and how to bring it to your doctor as useful information, not a confession.<\/p>\n This is not a willpower problem. It isn’t “in your head” in the dismissive sense that phrase implies \u2014 though, literally, it partly is, because the same brain chemistry regulating your mood also regulates your appetite.<\/p>\n A comprehensive 2025 clinical review found that weight gain affects an estimated 55\u201365% of people on long-term antidepressant therapy<\/strong> \u2014 one of the single most common side effects in psychiatry, not a rare reaction. The mechanisms are specific and increasingly well mapped:<\/p>\n This effect isn’t uniform across medications: tricyclic antidepressants and mirtazapine showed more substantial six-month gain (mirtazapine users gained close to 1.7 kg within 12 weeks in some studies), while SSRIs like escitalopram and paroxetine showed smaller short-term gains that compound beyond a year, and bupropion has been associated with modest weight loss. None of this is a reason to request a specific drug yourself \u2014 that decision belongs to you and your psychiatrist, weighed against symptom control.<\/p>\n Weight change also follows a pattern: little change, or mild loss from early nausea, in months one to three; gradual gain, when it happens, more often after three to six months, as receptor changes accumulate. Stability early on doesn’t rule out a later shift, and a shift doesn’t mean it climbs indefinitely.<\/p>\n Everything above concerns antidepressants. Antipsychotic medications \u2014 prescribed for schizophrenia, bipolar disorder, and sometimes added for treatment-resistant depression \u2014 carry their own, generally more pronounced, metabolic profile, worth a brief separate mention.<\/p>\n Some atypical (second-generation) antipsychotics act on histamine H1 and serotonin 5-HT2C receptors in ways that increase appetite substantially, and can independently lower resting energy expenditure \u2014 the calories your body burns at rest. In major trials tracking patients over roughly a year, average weight gain varied widely by medication: some options showed gains under 5 kg, others well over 10 kg, with corresponding differences in blood sugar and insulin sensitivity. This is why psychiatrists increasingly build metabolic risk into choosing and monitoring antipsychotic treatment, alongside periodic weight, blood sugar, and lipid checks. If you’re on one and haven’t had this conversation with your doctor, it’s reasonable and welcome to start \u2014 not a sign anything has gone wrong.<\/p>\n Every difficulty above sits inside a larger, India-specific silence. The National Mental Health Survey (NMHS) of India, 2015\u201316<\/strong> \u2014 still the country’s most comprehensive study of its kind \u2014 found 10.56% of Indian adults living with a current mental health condition<\/strong> and 13.67% affected in their lifetime<\/strong>, projecting to nearly 150 million Indians in need of care<\/strong>. Depression’s lifetime prevalence was 5.2%. Yet India’s overall treatment gap sits at roughly 84\u201385%<\/strong> \u2014 of 150 million in need, fewer than 30 million are in active treatment.<\/p>\n Part of this is structural: India has an estimated 0.75 psychiatrists per 100,000 people<\/strong> against a global average of roughly 4.7, with close to 80% concentrated in cities. But part of it is cultural \u2014 stigma is consistently cited as the single biggest barrier to seeking mental health treatment in India, illness still widely perceived as a personal weakness or spiritual failing rather than a medical condition, the way diabetes or high blood pressure would be.<\/p>\n This is why a body composition change, layered on a psychiatric diagnosis, becomes doubly hard to raise. Someone who has already fought for a family’s acceptance of their diagnosis is often reluctant to add “and now I’m gaining weight” to a conversation that felt hard-won. For many Indian women, where family commentary about weight can be unusually direct, this compounds an already heavy burden \u2014 exactly why it deserves to be said out loud, in a clinical setting, as medicine rather than moral failure.<\/p>\n Worth noting: SSRIs are the backbone of psychiatric prescribing in India. One multi-centre study across five tertiary psychiatric centres found 62.2% of antidepressant prescriptions were SSRIs<\/strong>, with escitalopram alone over a third of all use nationally \u2014 meaning the questions here concern a very large, largely silent population.<\/p>\n Here is where the anxiety of “the scale moved” can actually be defused with information, not willpower.<\/p>\n A bathroom scale reports one number: total body weight. It cannot distinguish water, muscle, and fat \u2014 three tissues that respond to psychiatric medication in different ways and timelines. Fluid shifts are a separate, documented phenomenon: certain SSRIs have been associated with mild fluid retention via effects on antidiuretic hormone regulation, described in case reports, most often early in treatment or after a dose change. A few kilograms of movement soon after starting a medication may reflect this temporary water shift far more than new fat tissue \u2014 a scale alone can’t tell you which.<\/p>\n A body composition analysis splits that single number into its real components: Skeletal Muscle Mass, Percent Body Fat, Visceral Fat Area, and total body water (intracellular and extracellular). That’s genuinely more useful than a frightening figure climbing on a scale \u2014 a trend line in the tissue that’s actually changing, tracked over months alongside your treatment rather than in competition with it.<\/p>\n This matters clinically, not only emotionally. Fat mass staying flat while water shifts is a very different conversation than fat mass climbing steadily across tests \u2014 only one of those patterns is a metabolic-side-effect conversation worth raising proactively. Either way, the goal is the same: replace an anxious guess with a measurement, so the conversation with your psychiatrist is about data, not fear.<\/p>\n Every recommendation below starts from one non-negotiable premise: do not stop, reduce, or skip your psychiatric medication because of weight or body composition concerns without talking to the doctor who prescribed it, first.<\/strong> Untreated depression, anxiety, or a psychotic disorder carries serious health risks of its own \u2014 often risks that outweigh the metabolic side effects discussed here. Each strategy below is meant to work alongside your treatment, as information you bring into the room, never a decision you make alone.<\/p>\n Because it isn’t primarily about eating more \u2014 it’s receptor-level change. Long-term SSRI use can desensitise the serotonin receptors that normally signal fullness, while shifting ghrelin, leptin, and cortisol toward fat storage. It’s a documented, chemical effect reported in more than half of people on long-term antidepressant therapy \u2014 not reduced willpower or a personal failing.<\/p>\n<\/div>\n No. Research comparing classes over six months found real differences: tricyclic antidepressants, MAOIs, and mirtazapine were linked to the largest gains; common SSRIs like escitalopram and paroxetine showed smaller, more gradual effects; bupropion was associated with modest weight loss in some studies. Never switch medications based on this alone \u2014 discuss trade-offs with your prescribing doctor, since symptom control matters most.<\/p>\n<\/div>\n Generally, yes \u2014 more pronounced. Some atypical antipsychotics act on appetite and metabolic-rate pathways more strongly than most antidepressants, and trials have recorded average gains from under 5 kg to over 10 kg across a year, depending on the medication. This is why metabolic monitoring \u2014 weight, blood sugar, lipids \u2014 is standard care for many people on antipsychotic treatment.<\/p>\n<\/div>\n A bathroom scale can’t tell the difference \u2014 it reports one combined number. A body composition test splits weight into water, muscle, and fat, showing whether an increase reflects fluid retention (a known, usually temporary effect of some SSRIs) or a genuine rise in fat mass \u2014 far less alarming, and far more useful to discuss with your doctor, than a single climbing number.<\/p>\n<\/div>\n No \u2014 not on your own, and not because of weight alone. Stopping psychiatric medication without supervision risks relapse of the underlying condition, usually a far more serious risk than the metabolic side effect. If the weight gain is genuinely distressing, tell your prescribing doctor directly so you can address it together \u2014 through monitoring, lifestyle support, or an adjustment they oversee.<\/p>\n<\/div>\n It varies by person and medication \u2014 research here is still developing. Some weight-related effects stabilise on continued treatment; others partially improve if a dose or medication is changed under medical supervision. This uncertainty is itself a reason to track body composition over time with your doctor, rather than guessing \u2014 never a reason to stop medication independently to “test” what happens.<\/p>\n<\/div>\n![\"LookinBody](\"https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/08\/lookinbody-software-dashboard.jpg\")
Why Some Psychiatric Medications Change Appetite and Metabolism: The Actual Science<\/h2>\n
\n
A Brief, Honest Note on Antipsychotic Medications<\/h2>\n
![\"InBody](\"https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/08\/inbody-dial-h20-app.jpg\")
Why This Is Even Harder to Talk About in India<\/h2>\n
Why Body Composition \u2014 Not the Bathroom Scale \u2014 Tells You What’s Actually Happening<\/h2>\n
What to Actually Do \u2014 With Your Prescribing Doctor, Never Instead of Them<\/h2>\n
\n
\nFrequently Asked Questions<\/h2>\n
Why am I gaining weight on my antidepressant even though I haven’t changed how I eat?<\/h3>\n
Do all antidepressants cause weight gain?<\/h3>\n
Is antipsychotic-related weight gain different from antidepressant weight gain?<\/h3>\n
How do I know if it’s water weight or actual fat gain?<\/h3>\n
Should I stop my medication because of the weight gain?<\/h3>\n
Will the weight gain reverse if I keep taking the medication, or if I stop?<\/h3>\n